2014 annual financial data
Nektar Therapeutics 2014 Operating margin
Nektar Therapeutics 2014 operating margin with verified reported values.
Direct answer
Operating margin was -8.21%.
Operating income was -16,485,000 USD and net income was -53,916,000 USD.
Operating cash flow was -142,006,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 200,707,000 USD
- Operating income
- -16,485,000 USD
- Net income
- -53,916,000 USD
- Operating cash flow
- -142,006,000 USD